According to VistaGen Therapeutics 's latest financial reports the company's current earnings (TTM) are -A$56.51 M. In 2023 the company made an earning of -A$50.19 M an increase over its 2022 earnings that were of -A$94.35 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.